PRISCILLA BORREGO: Open Payments
NPI 1346231768 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,381 in 146 payments from 14 companies in 2025. Trend: 2023 $2,951 · 2024 $4,844 · 2025 $3,381
Food & beverage: $3,306Education: $76
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $592 |
| Teva Pharmaceuticals USA, Inc. | 16 | $508 |
| ABBVIE INC. | 21 | $339 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $335 |
| Alkermes, Inc. | 16 | $290 |
| Janssen Pharmaceuticals, Inc | 17 | $285 |
| Otsuka America Pharmaceutical, Inc. | 14 | $259 |
| Lundbeck LLC | 13 | $235 |
| Axsome Therapeutics, Inc. | 5 | $211 |
| Vanda Pharmaceuticals Inc. | 7 | $149 |
Products named: COBENFY, REXULTI, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, Auvelity, ARISTADA.
Industry payments across FL — which companies pay providers there.
